Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.
Saved in:
| Title: | Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. |
|---|---|
| Authors: | Boer, S M de1 s.m.de_boer.onco@lumc.nl, Wortman, B G2, Bosse, T3, Powell, M E4, Singh, N5, Hollema, H6, Wilson, G7, Chowdhury, M N5, Mileshkin, L8, Pyman, J9 |
| Source: | Annals of Oncology. Feb2018, Vol. 29 Issue 2, p424-430. 7p. 1 Diagram, 3 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdx753 |
